T1000	Negation 822 828	lacked
E1000	Negation:T1000 Scope:T1001
T1001	Span 822 928	lacked MGMT promoter hypermethylation and 9 (75%) showed high MGMT protein expression (>50% tumoral cells)
T1002	Negation 227 229	no
E1001	Negation:T1002 Scope:T1003
T1003	Span 227 283	no convincing data on an effective role for chemotherapy
T1004	Speculation 1025 1028	may
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1025 1119	may indicate MGMT as a factor of chemoresistance to alkylating drugs in anaplastic ependymomas
T1006	Negation 997 1000	not
E1003	Negation:T1006 Scope:T1007
T1007	Span 930 1009	Differences between different recurrences in the same patient were not observed
T1008	Speculation 1029 1037	indicate
E1004	Speculation:T1008 Scope:T1009
T1009	Span 1029 1235	indicate MGMT as a factor of chemoresistance to alkylating drugs in anaplastic ependymomas and support the uncertainties regarding the actual benefit of chemotherapy for patients with anaplastic ependymomas
